Earnings call transcripts

Earnings call transcripts with speakers and Q&A, usually within hours. Each one comes with a summary, the guidance management gave, and what analysts pressed on, free to read.

3,600 transcripts · 1,695 companiesHow to read a callBy API: the earnings call transcripts API.

Older calls

Page 89 of 300 · 3,600 calls

  • Iovance Biotherapeutics (IOVA) Q2 2026 earnings call

    Management framed the quarter as proof that demand, manufacturing scale and cost discipline are improving together, while deferring revised full-year guidance until Q3 visibility improves.

    Aug 06, 2026Confident0.82
  • ITT (ITT) Q2 2026 earnings call

    Management framed Q2 as accelerating strategic momentum, with legacy share gains and acquisitions compounding growth while SPX Flow integration remains the key execution opportunity.

    Aug 06, 2026Confident0.82
  • Ligand Pharmaceuticals (LGND) Q2 2026 earnings call

    Management framed the quarter as validation of its royalty-aggregation strategy, with Zoma adding scale and duration while keeping underwriting discipline unchanged.

    Aug 06, 2026Confident0.78
  • MKS (MKSI) Q2 2026 earnings call

    Management framed the cycle as accelerating across semiconductors and advanced packaging, with capacity investment and customer visibility supporting continued outperformance.

    Aug 06, 2026Confident0.82
  • Orion (OEC) Q2 2026 earnings call

    Management framed the quarter as proof of resilience and execution, while emphasizing specialty strength, working-capital gains, and favorable trade dynamics against limited visibility.

    Aug 06, 2026Positive0.65
  • Praxis Precision Medicines (PRAX) Q2 2026 earnings call

    Management framed the quarter as the transition from development to launch execution, while emphasizing regulatory progress and a disciplined pause on FDA updates.

    Aug 06, 2026Confident0.78
  • Restaurant Brands International (QSR) Q2 2026 earnings call

    Management framed Q2 as evidence that brand-specific investments are driving broad growth, while stressing Burger King’s turnaround remains early and Popeyes is still recovering. Burger King U.S.

    Aug 06, 2026Confident0.72
  • Smith Douglas Homes (SDHC) Q2 2026 earnings call

    Management framed growth as a pace-versus-price tradeoff, with affordability incentives supporting orders while compressing margins and no full-year outlook offered.

    Aug 06, 2026Mildly positive0.25
  • Molson Coors Beverage (TAP) Q2 2026 earnings call

    Management framed Q2 as a volatile, pressured quarter but stressed portfolio flexibility, early share progress and unchanged FY26 guidance.

    Aug 06, 2026Cautious-0.15
  • Unity Software (U) Q2 2026 earnings call

    AI-driven product improvements and runtime data framed the growth flywheel, while disciplined cost choices were positioned to support growth and profitability together.

    Aug 06, 2026Confident0.88
  • Vse (VSEC) Q2 2026 earnings call

    Management framed the quarter as evidence of core-business momentum, with acquisition integration still early and most synergies expected beyond 2026.

    Aug 06, 2026Confident0.78
  • Zoetis (ZTS) Q2 2026 earnings call

    Management framed the reset as a response to worsening companion-animal demand and promotional competition, while stressing disciplined defense of share and long-term portfolio value.

    Aug 06, 2026Negative-0.45

Companies covered

1,695 companies

160 more under A